Summary:
The purpose of this study is to determine the analgesic efficacy of Egalet-002 twice daily (BID) in patients with moderate-to-severe chronic low back pain.
Qualified Participants Must:
• Be between 18 and 75 years of age (Adult, Senior)
•
Have had back pain for at least 6 months
Qualified Participants May Receive:
Study-related medical care and investigational medication at no cost and may be compensated for time and travel.